Information Journal Paper
APA:
Copy. (2020). Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia. JOURNAL OF HEMATOLOGY AND ONCOLOGY, 13(-), 1-10. SID. https://sid.ir/paper/779616/en
Vancouver:
Copy. Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia. JOURNAL OF HEMATOLOGY AND ONCOLOGY[Internet]. 2020;13(-):1-10. Available from: https://sid.ir/paper/779616/en
IEEE:
Copy, “Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia,” JOURNAL OF HEMATOLOGY AND ONCOLOGY, vol. 13, no. -, pp. 1–10, 2020, [Online]. Available: https://sid.ir/paper/779616/en